ADME 101: DMPK and ADME in Drug Development

1,960 views

|

October 17, 2019

Presenter: Joanna Barbara, Ph.D., Vice President of Scientific Operations at SEKISUI XenoTech

We are pleased to present SEKISUI XenoTech’s first ADME 101 series webinar, Acronyms Abound: DMPK and ADME in Drug Development. ADME 101 is a comprehensive new collection of educational short videos to serve as a resource for researchers and industry professionals to navigate ADME, DMPK, and DDI within the complex landscape of drug development. As we continue to update and add to our repository of resources, we welcome questions and requests for topics our experts may address in future presentations. Please use our online forms to request a topic or get in touch with our team.

Key concepts discussed in this webinar will include:
The overarching aim of therapeutic drug development
DMPK – Drug metabolism and pharmacokinetics
- Based on ADME properties
- Relationship to Drug-Drug Interactions (DDI)
ADME properties
A hint of DDI

Download a copy of the slides: https://www.xenotech.com/webinar-slides/adme-101-dmpk-and-adme-in-drug-development.pdf
Questions, comments and requests: https://www.xenotech.com/contact-us
More information on our research services and test systems: https://www.xenotech.com
Other previously aired webinars: https://www.xenotech.com/scientific-resources/webinar-series
Upcoming webinar notifications: https://www.xenotech.com/newsletter-signup
Request a webinar topic: https://www.xenotech.com/scientific-resources/upcoming-webinars

BiopharmaCancer ResearchDrug Discovery

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.